DOI QR코드

DOI QR Code

Inflammation and Insufficient or Disordered Sleep

염증 반응과 수면 장애

  • Lee, Suk Jun (Department of Biomedical Laboratory Science, College of Health Science, Cheongju University) ;
  • Kim, Jinkwan (Department of Biomedical Laboratory Science, College of Health Science, Jungwon University)
  • 이석준 (청주대학교 보건의료대학 임상병리학과) ;
  • 김진관 (중원대학교 의료보건대학 임상병리학과)
  • Received : 2015.05.26
  • Accepted : 2015.06.14
  • Published : 2015.09.30

Abstract

Sleep is not only an essential physiological function, but also serves important roles in promoting growth, maturation, and overall health of humans. There is increasing interest regarding the impact of sleep and its disorders on the regulation of inflammatory processes and end-organ morbidities, particularly in the context of metabolic and cardiovascular diseases (CVD) and their complications. Obstructive sleep apnea syndrome (OSAS) is an increasingly common health problem in children. In the last decade, the emergence of increasing obesity rates has further led to remarkable increases in the prevalence of OSAS, along with more prominent neurocognitive, behavioral, cardiovascular and metabolic morbidities. Although the underlying mechanisms leading to OSAS-induced morbidities are likely multifactorial and remain to be fully elucidated, activation of inflammatory pathways by OSAS has emerged as an important pathophysiological component of the end-organ injury associated with this disorder. To this effect, it would appear that OSAS could be viewed as a chronic, low-grade inflammatory disorder. Furthermore, the concurrent presence of obesity and OSAS poses a theoretically increased risk of OSAS-related complications. In this study, we will critically review the current state of research regarding the impact of insufficient and disrupted sleep and OSAS on the immune processes and inflammatory pathways that underlie childhood OSAS as a distinctive systemic inflammatory condition in children, and will explore potential interactions between OSAS and obesity.

수면현상은 인간의 삶의 1/3을 차지하는 중요한 생리적 현상으로 인간의 수면은 신체의 기능을 유지하기 위한 중요한 생리적 기능뿐 아니라 수면을 통한 휴식을 통하여 신체 건강을 유지하고 성장을 유지하는 중요한 역할을 한다. 최근의 급격한 산업화와 정보화로 인하여 급격한 사회 생활구조의 변화를 유발하여 성인뿐 아니라 소아에서도 평균수면 시간의 감소와 다양한 스트레스 환경으로 인한 수면의 질적 저하로 인한 다양한 수면 문제가 사회적 문제로 대두되고 있다. 단순히 수면 부족 또는 수면의 질적 저하뿐 아니라 수면 장애, 특히 폐쇄성 수면 무호흡증은 심혈관 질환뿐 아니라 비만, 대사증후군, 심혈관 질환, 뇌혈관 질환 등 의 다양한 만성 질병의 발생과 깊은 연관성이 있는 것으로 보고하고 있다. 특히 이러한 만성질환을 유발하는 핵심기전으로 염증 반응이 관여하고 있는 것으로 알려져 있으며, 따라서 수면 현상과 다양한 수면 장애에 대한 관심이 급격히 증가하고 있는 실정이다. 비록 수면 무호흡증으로 인한 이러한 질병의 이환에 대한 기전은 다양한 요인이 복합적으로 작용하는 것으로 알려져 있지만 핵심 기전으로 알려진 염증반응의 활성화가 병태 생리학적으로 중요한 역할을 하는 것으로 추측하고 있다. 따라서 최근 수면 무호흡증을 낮은 수준의 만성 염증 질환으로 인식되고 있으며, 더불어 비만과 수면무호흡증으로 인한 연관된 질병의 이환을 더욱 증가시키는 것으로 보고되고 있다. 따라서 본 종설에는 수면의 질적 또는 양적 저하뿐 아니라 폐쇄성 수면 무호흡증으로 인한 염증성 반응의 활성화가 인간의 신체 면역 과정 미치는 영향을 중심으로 최근의 연구 결과 및 수면 무호흡증과 비만의 잠재적 상호작용에 대하여 서술하고자 한다

Keywords

References

  1. Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci. 2001, 2:734-744 https://doi.org/10.1038/35094583
  2. Anderson SE, Whitaker RC. Household routines and obesity in US preschool-aged children. Pediatrics. 2010, 125:420-428 https://doi.org/10.1542/peds.2009-0417
  3. Benca RM, Kushida CA, Everson CA, et al. Sleep deprivation in the rat: VII. Immune function. Sleep. 1989, 12:47-52 https://doi.org/10.1093/sleep/12.1.47
  4. Brandt JA, Churchill L, Rehman A, et al. Sleep deprivation increases the activation of nuclear factor kappa B in lateral hypothalamic cells. Brain Res. 2004, 1004:91-97 https://doi.org/10.1016/j.brainres.2003.11.079
  5. Brasier AR. The NF-kappaB regulatory network. Cardiovasc Toxicol. 2006, 6:111-130 https://doi.org/10.1385/CT:6:2:111
  6. Cappuccio FP, Taggart FM, Kandala NB, et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep. 2008, 31:619-626 https://doi.org/10.1093/sleep/31.5.619
  7. Chassin L, Presson CC, Rose J, et al. Parenting style and smoking-specific parenting practices as predictors of adolescent smoking onset. J Pediatr Psychol. 2005, 30:333-344 https://doi.org/10.1093/jpepsy/jsi028
  8. Chaput JP, Brunet M, Tremblay A. Relationship between short sleeping hours and childhood overweight/obesity: results from the 'Quebec en Forme' Project. Int J Obes (Lond). 2006, 30:1080-1085 https://doi.org/10.1038/sj.ijo.0803291
  9. Dantzer R, O'Connor JC, Freund GG, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008, 9:46-56 https://doi.org/10.1038/nrn2297
  10. Dyugovskaya L, Lavie P, Hirsh M, et al. Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur Respir J. 2005, 25:820-828 https://doi.org/10.1183/09031936.05.00103204
  11. Farre R, Montserrat JM, Navajas D. Morbidity due to obstructive sleep apnea: insights from animal models. Curr Opin Pulm Med. 2008, 14:530-536 https://doi.org/10.1097/MCP.0b013e328312ed76
  12. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006; 43:S99-S112 https://doi.org/10.1002/hep.20973
  13. Feuerer M, Herrero L, Cipolletta D, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med. 2009, 15:930-939 https://doi.org/10.1038/nm.2002
  14. Ford ES. C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation. 2003, 108:1053-1058 https://doi.org/10.1161/01.CIR.0000080913.81393.B8
  15. Franklin CM. Clinical experience with soluble TNF p75 receptor in rheumatoid arthritis. Semin Arthritis Rheum. 1999, 29:172-181 https://doi.org/10.1016/S0049-0172(99)80028-6
  16. Gozal D. Sleep, sleep disorders and inflammation in children. Sleep Med. 2009, Supple 1:S12-16
  17. Gozal D, Serpero LD, Sans Capdevila O, et al. Systemic inflammation in non-obese children with obstructive sleep apnea. Sleep Med. 2008, 9:254-259 https://doi.org/10.1016/j.sleep.2007.04.013
  18. Gozal D, Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med. 2008, 177:369-375 https://doi.org/10.1164/rccm.200608-1190PP
  19. Guilleminault C, Kirisoglu C, Ohayon MM. C-reactive protein and sleep-disordered breathing. Sleep. 2004, 27:1507-1511 https://doi.org/10.1093/sleep/27.8.1507
  20. Horne J. Short sleep is a questionable risk factor for obesity and related disorders: statistical versus clinical significance. Biol Psychol. 2008, 77:266-276 https://doi.org/10.1016/j.biopsycho.2007.12.003
  21. Hein TW, Singh U, Vasquez-Vivar J, et al. Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis. 2009, 206:61-68 https://doi.org/10.1016/j.atherosclerosis.2009.02.002
  22. Ievers-Landis CE, Redline S. Pediatric sleep apnea: implications of the epidemic of childhood overweight. Am J Respir Crit Care Med. 2007, 175:436-441 https://doi.org/10.1164/rccm.200606-790PP
  23. Irwin MR, Wang M, Campomayor CO, et al. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Arch Intern Med. 2006, 166:1756-1762 https://doi.org/10.1001/archinte.166.16.1756
  24. Irwin MR, Wang M, Ribeiro D, et al. Sleep loss activates cellular inflammatory signaling. Biol Psychiatry. 2008, 64:538-540 https://doi.org/10.1016/j.biopsych.2008.05.004
  25. Jiang F, Zhu S, Yan C, et al. Sleep and obesity in preschool children. J Pediatr. 2009, 154:814-818 https://doi.org/10.1016/j.jpeds.2008.12.043
  26. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005, 26:439-451 https://doi.org/10.1210/er.2005-0005
  27. Kritchevsky SB, Cesari M, Pahor M. Inflammatory markers and cardiovascular health in older adults. Cardiovasc Res. 2005, 66:265-275 https://doi.org/10.1016/j.cardiores.2004.12.026
  28. Krueger JM, Obal FJ, Fang J, et al. The role of cytokines in physiological sleep regulation. Ann N Y Acad Sci. 2001, 933:211-221
  29. Krueger JM. The role of cytokines in sleep regulation. Curr Pharm Des. 2008, 14:3408-3416 https://doi.org/10.2174/138161208786549281
  30. Kuo TH, Pike DH, Beizaeipour Z, et al. Sleep triggered by an immune response in Drosophila is regulated by the circadian clock and requires the NFkappaB Relish. BMC Neurosci. 2010, 11:17 https://doi.org/10.1186/1471-2202-11-17
  31. Lago R, Gomez R, Lago F, et al. Leptin beyond body weight regulation--current concepts concerning its role in immune function and inflammation. Cell Immunol. 2008, 252:139-145 https://doi.org/10.1016/j.cellimm.2007.09.004
  32. Lavie L, Lavie P. Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J. 2009, 33:1467-1484 https://doi.org/10.1183/09031936.00086608
  33. Leproult R, Van Cauter E. Role of sleep and sleep loss in hormonal release and metabolism. Endocr Dev. 2010, 17:11-21
  34. Li AM, Chan MH, Yin J, et al. C-reactive protein in children with obstructive sleep apnea and the effects of treatment. Pediatr Pulmonol. 2008, 43:34-40 https://doi.org/10.1002/ppul.20732
  35. Lusis AJ. Atherosclerosis. Nature. 2000, 407:233-241 https://doi.org/10.1038/35025203
  36. Marcheva B, Ramsey KM, Buhr ED, et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature. 2010, 466:627-631 https://doi.org/10.1038/nature09253
  37. Marz P, Cheng JG, Gadient RA, et al. Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci U S A. 1998, 95:3251-3256 https://doi.org/10.1073/pnas.95.6.3251
  38. Matsuzawa Y. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2006, 3:35-42 https://doi.org/10.1038/ncpcardio0380
  39. McNicholas WT. Obstructive sleep apnea and inflammation. Prog Cardiovasc Dis. 2009, 51:392-399 https://doi.org/10.1016/j.pcad.2008.10.005
  40. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 140:771-776
  41. Mehra R, Storfer-Isser A, Kirchner HL, et al. Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder. Arch Intern Med. 2006, 166:1725-1731 https://doi.org/10.1001/archinte.166.16.1725
  42. Must A, Parisi SM. Sedentary behavior and sleep: paradoxical effects in association with childhood obesity. Int J Obes (Lond). 2009, 33 Suppl 1:S82-86
  43. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA. 2006, 295:1549-1555 https://doi.org/10.1001/jama.295.13.1549
  44. Opp MR. Sleep and psychoneuroimmunology. Immunol Allergy Clin North Am. 2009, 29:295-307 https://doi.org/10.1016/j.iac.2009.02.009
  45. Ouchi N, Parker JL, Lugus JJ, et al. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011, 11:85-97 https://doi.org/10.1038/nri2921
  46. Pack AI, Gislason T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog Cardiovasc Dis. 2009, 51:434-451 https://doi.org/10.1016/j.pcad.2009.01.002
  47. Pecchi E, Dallaporta M, Jean A, et al. Prostaglandins and sickness behavior: old story, new insights. Physiol Behav. 2009, 97:279-292 https://doi.org/10.1016/j.physbeh.2009.02.040
  48. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007, 8:49-62 https://doi.org/10.1038/nrm2083
  49. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006, 113:898-918 https://doi.org/10.1161/CIRCULATIONAHA.106.171016
  50. Ranjbaran Z, Keefer L, Stepanski E, et al. The relevance of sleep abnormalities to chronic inflammatory conditions. Inflamm Res. 2007, 56:51-57 https://doi.org/10.1007/s00011-006-6067-1
  51. Rechtschaffen A, Bergmann BM. Sleep deprivation and host defense. Am J Physiol Regul Integr Comp Physiol. 2001, 280:R602-603 https://doi.org/10.1152/ajpregu.2001.280.2.R602
  52. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000, 342:836-843 https://doi.org/10.1056/NEJM200003233421202
  53. Spath-Schwalbe E, Hansen K, Schmidt F, et al. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol. Metab 1998, 83:1573-1579
  54. Spiegel K, Tasali E, Penev P, et al. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004, 141:846-850 https://doi.org/10.7326/0003-4819-141-11-200412070-00008
  55. Spruyt K, Molfese DL, Gozal D. Sleep Duration, Sleep Regularity, Body Weight, and Metabolic Homeostasis in School-aged Children. Pediatrics. 2011, 127:e345-352 https://doi.org/10.1542/peds.2010-0497
  56. Suganami T, Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol. 2010, 88:33-39 https://doi.org/10.1189/jlb.0210072
  57. Suzuki YJ, Jain V, Park AM, et al. Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 2006, 40:1683-1692 https://doi.org/10.1016/j.freeradbiomed.2006.01.008
  58. Takahashi S, Kapas L, Fang J, et al. Somnogenic relationships between tumor necrosis factor and interleukin-1. Am J Physiol. 1999, 276:R1132-1140 https://doi.org/10.1152/ajpcell.1999.276.5.C1132
  59. Valleggi S, Devaraj S, Dasu MR, et al. C-reactive protein adversely alters the protein-protein interaction of the endothelial isoform of nitric oxide synthase. Clin Chem. 2010, 56:1345-1348 https://doi.org/10.1373/clinchem.2009.142364
  60. Van Cauter E, Spiegel K, Tasali E, et al. Metabolic consequences of sleep and sleep loss. Sleep Med. 2008, 9 Suppl 1:S23-28
  61. Vgontzas AN, Bixler EO, Chrousos GP. Obesity-related sleepiness and fatigue: the role of the stress system and cytokines. Ann N Y Acad Sci. 2006, 1083:329-344 https://doi.org/10.1196/annals.1367.023
  62. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab. 1997, 82:1313-1316 https://doi.org/10.1210/jcem.82.5.3950
  63. Visser M, Bouter LM, McQuillan GM, et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999, 282:2131-2135 https://doi.org/10.1001/jama.282.22.2131
  64. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003, 107:1129-1134 https://doi.org/10.1161/01.CIR.0000052627.99976.18
  65. Yu YH, Ginsberg HN. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res. 2005, 96:1042-1052 https://doi.org/10.1161/01.RES.0000165803.47776.38

Cited by

  1. 수면장애와 졸음운전의 상관성 vol.47, pp.4, 2015, https://doi.org/10.15324/kjcls.2015.47.4.216
  2. 관절염 치료에 사용되는 한약재들의 항 염증 활성과 기전에 관한 연구 vol.48, pp.3, 2015, https://doi.org/10.15324/kjcls.2016.48.3.176
  3. Mediating Effect of Stress on the Relationship between Illness Perception and Sleep in Patients at Risk of Metabolic Syndrome vol.31, pp.4, 2015, https://doi.org/10.7475/kjan.2019.31.4.449
  4. 자하거 약침이 만성 신체 스트레스 모델 백서의 행동, 체중, 수면 호르몬, 염증 사이토카인, 항산화 효소의 변화에 미치는 영향 vol.30, pp.4, 2019, https://doi.org/10.7231/jon.2019.30.4.357
  5. 생산직 근로자의 수면시간과 수면의 질이 대사증후군 및 대사증후군 구성요소 유병률에 미치는 영향 vol.29, pp.1, 2015, https://doi.org/10.5807/kjohn.2020.29.1.69
  6. Obesity, Obstructive Sleep Apnea, and Metabolic Dysfunction vol.53, pp.4, 2015, https://doi.org/10.15324/kjcls.2021.53.4.285